ARS Pharmaceuticals Inc’s recent filing unveils that its Officer Chakma Justin acquired Company’s shares for reported $0.65 million on Dec 02 ’24. In the deal valued at $14.51 per share,45,000 shares were bought.
Then, Shawver Laura bought 200,000 shares, generating $2,713,000 in total proceeds.
Before that, ERIC KARAS bought 3,717 shares. ARS Pharmaceuticals Inc shares valued at $52,461 were divested by the Officer at a price of $14.11 per share.
Cantor Fitzgerald initiated its ARS Pharmaceuticals Inc [SPRY] rating to an Overweight in a research note published recently. A number of analysts have revised their coverage, including Raymond James’s analysts, who increased its forecast for the stock in mid August from “an Outperform” to “a Strong buy”. Leerink Partners also remained covering SPRY and reiterated its “an Outperform” recommendation on August 12, 2024. Raymond James started covering the stock on July 25, 2024. It rated SPRY as “an Outperform”.
Price Performance Review of SPRY
On Monday, ARS Pharmaceuticals Inc [NASDAQ:SPRY] saw its stock fall -8.20% to $13.32. Over the last five days, the stock has lost -4.86%. ARS Pharmaceuticals Inc shares have risen nearly 143.07% since the year began. Nevertheless, the stocks have risen 175.78% over the past one year. While a 52-week high of $18.51 was reached on 11/11/24, a 52-week low of $4.76 was recorded on 01/04/24. SMA at 50 days reached $14.79, while 200 days put it at $11.14.
Levels Of Support And Resistance For SPRY Stock
The 24-hour chart illustrates a support level at 12.92, which if violated will result in even more drops to 12.52. On the upside, there is a resistance level at 14.06. A further resistance level may holdings at 14.79. The Relative Strength Index (RSI) on the 14-day chart is 40.18, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.01, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 93.66%. Stochastics %K at 20.42% indicates the stock is a holding.
How much short interest is there in ARS Pharmaceuticals Inc?
A steep rise in short interest was recorded in ARS Pharmaceuticals Inc stocks on 2024-11-15, growing by 1.94 million shares to a total of 13.85 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-15 was 11.92 million shares. There was a rise of 13.98%, which implies that there is a positive sentiment for the stock.
